Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026

Go back to Verastem Oncology to Report First Quarter 2026 Financial Results on May 7, 2026
VERASTEM SHS (NASDAQ: VSTM) Delayed: 4.26 +0.01 (0.24%)
Previous Close $4.25    52 Week High $2.43 
Open $4.19    52 Week Low $1.05 
Day High $4.41    P/E N/A 
Day Low $4.19    EPS $-1.79 
Volume 829,841